Presentation of Interleukin-12/-23 Receptor β1 Deficiency with Various Clinical Symptoms of Salmonella Infections
- 1 January 2006
- journal article
- case report
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 26 (1) , 1-6
- https://doi.org/10.1007/s10875-006-7830-3
Abstract
Clinical disease caused by weakly pathogenic mycobacterial species, Mycobacterium bovis Bacille Calmette-Guérin (BCG) and non-tuberculous environmental mycobacteria (EM), which is known as Mendelian susceptibility to mycobacterial disease (MSMD), is a rare entity defined recently. Infections with the more virulent Mycobacterium species, M. tuberculosis, may have largely gone unnoticed in these patients due to early death. Mutations in five proteins (IFNγR1, IFNγR2, IL-12/IL-23Rβ1, IL-12/IL-23p40 and STAT1) have been found in MSMD. These patients are prone to surprisingly few other infectious diseases mainly to salmonellosis. Here we present three IL-12/IL-23Rβ1 deficient patients from three different families and with different genetic mutations, who presented exclusively with Salmonella infections. Bacteremia and lymph node involvement were common clinical expressions. Leukocytoclastic vasculitis developed in one of these patients. Two patients were not inoculated with BCG, the third patient did not develop BCG infection although BCG vaccine had been given twice at ages of 1 and 7 years. All three patients responded well to antibiotic treatment. In conclusion, patients with chronic, recurrent or complicated Salmonella infections should be screened for MSMD, particularly for IL-12/IL-23p40/IL-12R/-23Rβ1 deficiency. Conversely, in patients with genetic IL-12/-23Rβ1 deficiency a full evaluation for Salmonella infection is required. IL-12/IL-23p40/IL-12R/IL-23Rβ1 deficiency seem to be underdiagnosed in patients with salmonellosis, and since such patients need prolonged therapy, diagnosis is important.Keywords
This publication has 16 references indexed in Scilit:
- Clinical features of dominant and recessive interferon γ receptor 1 deficienciesThe Lancet, 2004
- Interleukin (IL)–12 and IL‐23 Are Key Cytokines for Immunity against Salmonella in HumansThe Journal of Infectious Diseases, 2004
- Clinical Tuberculosis in 2 of 3 Siblings with Interleukin-12 Receptor 1 DeficiencyClinical Infectious Diseases, 2003
- Interleukin-12 Receptor β1 Deficiency Presenting as Recurrent Salmonella InfectionClinical Infectious Diseases, 2003
- Mini‐review The role of interleukin‐12 in human infectious diseases: only a faint signatureEuropean Journal of Immunology, 2003
- Low Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor β1 DeficiencyThe Journal of Experimental Medicine, 2003
- Severe Mycobacterium bovis BCG infections in a large series of novel IL–12 receptor β1 deficient patients and evidence for the existence of partial IL–12 receptor β1 deficiencyEuropean Journal of Immunology, 2002
- Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellaeNature Genetics, 2002
- Genetic Dissection of Immunity to Mycobacteria: The Human ModelAnnual Review of Immunology, 2002
- Interleukin‐12 Receptor β1 Deficiency in a Patient with Abdominal TuberculosisThe Journal of Infectious Diseases, 2001